These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 25255580)
1. Risk factors and prescription patterns of gastroesophageal reflux disease: HEAL study in Pakistan. Butt AK; Hashemy I J Pak Med Assoc; 2014 Jul; 64(7):751-7. PubMed ID: 25255580 [TBL] [Abstract][Full Text] [Related]
12. Do pediatricians apply the 2009 NASPGHAN-ESPGHAN guidelines for the diagnosis and management of gastroesophageal reflux after being trained? Quitadamo P; Urbonas V; Papadopoulou A; Roman E; Pavkov DJ; Orel R; Dias JA; Kostovski A; Miele E; Villani A; Staiano A J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):356-9. PubMed ID: 24762458 [TBL] [Abstract][Full Text] [Related]
13. European pediatricians' approach to children with GER symptoms: survey of the implementation of 2009 NASPGHAN-ESPGHAN guidelines. Quitadamo P; Papadopoulou A; Wenzl T; Urbonas V; Kneepkens CM; Roman E; Orel R; Pavkov DJ; Dias JA; Vandenplas Y; Kostovski A; Miele E; Villani A; Staiano A J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):505-9. PubMed ID: 24663035 [TBL] [Abstract][Full Text] [Related]
14. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease. Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237 [TBL] [Abstract][Full Text] [Related]
15. [Symptom profile in gastroesophageal reflux disease in untreated patients and those with persistent symptoms despite treatment]. Ponce J; Mearin F; Ponce M; Balboa A; Zapardiel J Gastroenterol Hepatol; 2010 Apr; 33(4):271-9. PubMed ID: 20133018 [TBL] [Abstract][Full Text] [Related]
16. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients. Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659 [TBL] [Abstract][Full Text] [Related]
17. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000 [TBL] [Abstract][Full Text] [Related]
18. Management of reflux disease in clinical praxis in hungary. Hritz I; Prónai L; Szalay F; Tulassay Z Z Gastroenterol; 2005 Jun; 43(6):575-80. PubMed ID: 15986286 [TBL] [Abstract][Full Text] [Related]
19. [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?]. Mouterde O; Bellaïche M; Dumant C; Mallet E Arch Pediatr; 2010 Jun; 17(6):739-40. PubMed ID: 20654868 [No Abstract] [Full Text] [Related]
20. Influence on consumer behavior: the impact of direct-to-consumer advertising on medication requests for gastroesophageal reflux disease and social anxiety disorder. Khanfar NM; Polen HH; Clauson KA J Health Commun; 2009; 14(5):451-60. PubMed ID: 19657925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]